🟢 Insulet is trading 4.66% up today after Q3 revenue and EPS topped estimates

Insulet is trading at $162.07, up 4.66%, after Q3 revenue and adjusted EPS beat expectations.

• Q3 revenue reached $842 million, above expectations; adjusted EPS was $1.99, versus the $1.59 consensus.
• Insulet raised its 2026 revenue-growth outlook and authorized a $1 billion increase to its share-repurchase program.
• Shares rose from $154.86 at the November 3 close; broader market strength may also support the move.